Tolerance of diclofenac after hypersensitivity to celecoxib and to nabumetone. (Record no. 16150835)

MARC details
000 -LEADER
fixed length control field 01462 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515020759.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200609s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0306-5251
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/j.1365-2125.2005.02576.x
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Wyplosz, Benjamin
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20060911
245 00 - TITLE STATEMENT
Title Tolerance of diclofenac after hypersensitivity to celecoxib and to nabumetone.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. British journal of clinical pharmacology
Date of publication, distribution, etc. Apr 2006
300 ## - PHYSICAL DESCRIPTION
Extent 474 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Inflammatory Agents, Non-Steroidal
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Butanones
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Celecoxib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclooxygenase Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diclofenac
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Hypersensitivity
General subdivision etiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Knee Joint
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nabumetone
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Osteoarthritis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazoles
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfonamides
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vautier, Sarah
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lillo-Le Louët, Agnès
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Capron, Loïc
773 0# - HOST ITEM ENTRY
Title British journal of clinical pharmacology
Related parts vol. 61
-- no. 4
-- p. 474
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/j.1365-2125.2005.02576.x">https://doi.org/10.1111/j.1365-2125.2005.02576.x</a>
Public note Available from publisher's website

No items available.